The improved survival rate of S100a4−/− glioma-bearing mice was associated with the generation of anti-tumor immunity, accompanied by increased phagocytic activity of CD11b+ glioma-associated myeloid cells and enhanced activity of CD4+ T cells, stimulating T cell proliferation and IFNγ secretion (120). Here, CD4 is linked to central nervous system cancer.